ABLIM2 | Actin binding LIM protein family, member 2 | ![](/images/35808/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35808/69058_B_8_1_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | ![](/images/11887/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | | ![](/images/11887/29435_B_2_5_rna_selected_60x60.jpg) | N/A |
| | Tissue enhanced | 0 |
AC069368.3 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000397942} | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
ADRA1B | Adrenoceptor alpha 1B | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
AFAP1L2 | Actin filament associated protein 1-like 2 | ![](/images/37843/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/37843/76927_B_5_6_rna_selected_60x60.jpg) |
|
| Plasma membrane Cytoplasm | Tissue enhanced | 0 |
ALG1L2 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like 2 | ![](/images/60392/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/60392/ihc_cell_selected_60x60.jpg) | ![](/images/60392/137548_A_2_2_rna_selected_60x60.jpg) | N/A |
| | Tissue enhanced | 0 |
ANKRD33B | Ankyrin repeat domain 33B | ![](/images/56974/ihc_selected_60x60.jpg) | ![](/images/56974/1411_H9_3_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/56974/128850_B_9_1_rna_selected_60x60.jpg) |
|
| Mitochondria | Tissue enhanced | 0 |
AOAH | Acyloxyacyl hydrolase (neutrophil) | ![](/images/21666/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21666/48920_B_9_8_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
APLNR | Apelin receptor | ![](/images/25842/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25842/57364_B_7_7_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | ![](/images/40879/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40879/95140_B_9_1_rna_selected_60x60.jpg) | N/A |
| | Tissue enhanced | 0 |
C10orf105 | Chromosome 10 open reading frame 105 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
C19orf35 | Chromosome 19 open reading frame 35 | ![](/images/57806/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57806/131594_B_8_7_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
C5AR2 | Complement component 5a receptor 2 | ![](/images/16629/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16629/37314_B_8_2_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CABP4 | Calcium binding protein 4 | ![](/images/43702/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/43702/ihc_cell_selected_60x60.jpg) | ![](/images/43702/96517_B_8_1_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CARD9 | Caspase recruitment domain family, member 9 | ![](/images/59502/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/59502/133368_B_8_5_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CCL14 | Chemokine (C-C motif) ligand 14 | ![](/images/30268/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30268/63235_A_2_3_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CD160 | CD160 molecule | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CD163L1 | CD163 molecule-like 1 | | ![](/images/15663/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/15663/34961_B_8_1_rna_selected_60x60.jpg) |
|
| Nucleus but not nucleoli Cytoplasm Centrosome | Tissue enhanced | 0 |
CD226 | CD226 molecule | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/15715/37859_A_9_7_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CD244 | CD244 molecule, natural killer cell receptor 2B4 | ![](/images/10628/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10628/26149_B_8_2_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CD300LF | CD300 molecule-like family member f | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13712/117004_B_9_8_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CD37 | CD37 molecule | | ![](/images_static/na_center.gif) | | ![](/images/2492/6131_A_2_6_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CD7 | CD7 molecule | | ![](/images_static/na_center.gif) | ![](/images/39079/134055_A_2_5_selected_60x60.jpg) | ![](/images/2594/6570_B_9_3_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CD79A | CD79a molecule, immunoglobulin-associated alpha | | ![](/images_static/na_center.gif) | | ![](/images/19/395_A_8_8_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CD79B | CD79b molecule, immunoglobulin-associated beta | ![](/images/9178/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/9178/26322_A_7_7_rna_selected_60x60.jpg) |
|
| Nucleus but not nucleoli Plasma membrane Cytoplasm | Tissue enhanced | 0 |
CD8A | CD8a molecule | | ![](/images_static/na_center.gif) | ![](/images/37756/ihc_cell_selected_60x60.jpg) | ![](/images/12/106_B_1_7_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | ![](/images/15613/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/15613/35995_B_7_3_rna_selected_60x60.jpg) |
|
| Plasma membrane | Tissue enhanced | 0 |
CETP | Cholesteryl ester transfer protein, plasma | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CFP | Complement factor properdin | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CHRM4 | Cholinergic receptor, muscarinic 4 | ![](/images/22444/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22444/55132_B_9_2_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CHRNA4 | Cholinergic receptor, nicotinic, alpha 4 (neuronal) | ![](/images/34064/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34064/70739_B_8_2_rna_selected_60x60.jpg) | N/A |
| | Tissue enhanced | 0 |
CLEC4E | C-type lectin domain family 4, member E | ![](/images/4935/ihc_selected_60x60.jpg) | ![](/images/4935/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4935/13397_B_8_2_rna_selected_60x60.jpg) | N/A |
| Cytoplasm | Tissue enhanced | 0 |
CPLX3 | Complexin 3 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CR1 | Complement component (3b/4b) receptor 1 (Knops blood group) | | ![](/images/42455/if_selected_60x60.jpg) | ![](/images/2491/ihc_cell_selected_60x60.jpg) | ![](/images/2491/6134_B_1_3_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CRABP1 | Cellular retinoic acid binding protein 1 | ![](/images/17203/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17203/38529_B_8_5_rna_selected_60x60.jpg) | N/A |
| | Tissue enhanced | 0 |
CRHBP | Corticotropin releasing hormone binding protein | ![](/images/46120/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46120/103112_B_9_1_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
CXCL1 | Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CXCL6 | Chemokine (C-X-C motif) ligand 6 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
CXCR1 | Chemokine (C-X-C motif) receptor 1 | ![](/images/31991/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/31991/ihc_cell_selected_60x60.jpg) | ![](/images/31991/135677_B_8_3_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
DNASE1L3 | Deoxyribonuclease I-like 3 | ![](/images/19955/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19955/46712_B_8_6_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
EMR1 | Egf-like module containing, mucin-like, hormone receptor-like 1 | ![](/images/52809/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52809/119797_B_8_1_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
EOMES | Eomesodermin | ![](/images/28896/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28896/70213_A_3_6_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
EPHA8 | EPH receptor A8 | ![](/images/31433/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9660/24646_B_3_2_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
EXOC3L1 | Exocyst complex component 3-like 1 | ![](/images/29574/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/29574/61415_B_9_3_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
FAIM3 | Fas apoptotic inhibitory molecule 3 | ![](/images/3910/ihc_selected_60x60.jpg) | ![](/images/3910/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3910/11161_B_9_2_rna_selected_60x60.jpg) |
|
| Focal Adhesions Nucleus Cytoplasm | Tissue enhanced | 0 |
FAM110B | Family with sequence similarity 110, member B | ![](/images/8318/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/8318/22607_B_7_4_rna_selected_60x60.jpg) |
|
| Cytoplasm Mitochondria | Tissue enhanced | 0 |
FAM26F | Family with sequence similarity 26, member F | ![](/images/17948/ihc_selected_60x60.jpg) | ![](/images/62365/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/17948/40497_B_8_2_rna_selected_60x60.jpg) |
|
| Nucleus Nucleoli Centrosome | Tissue enhanced | 0 |
FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |
FCRL1 | Fc receptor-like 1 | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13323/30968_B_8_6_rna_selected_60x60.jpg) |
|
| | Tissue enhanced | 0 |
FCRL6 | Fc receptor-like 6 | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | |
| | Tissue enhanced | 0 |